Roche reports solid results in the first quarter of 2021

Group sales increase 3%1 at constant exchange rates (CER); 1% decline in Swiss francs, as a result of the appreciation of the Swiss franc
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news